Oral presentation

Oral presentations can cover: original research findings, case studies, completed projects and theoretical analysis. Presentations should be well structured, rigorous and demonstrate a novel contribution to knowledge.

Oral presentation

Presentations

5. Addressing substance use and related problems in reception settings in Europe

6. Caregiving packages in conflict and humanitarian settings for prevention of substance use and other health and social consequences and for child protection and development

7. Understanding and Responding to Substance Use and Abuse in the Palestinian Refugee Camps inLebanon Prior to and During COVID-19 Times

3. Handbook on Addressing Substance Use Disorders in Humanitarian Settings – Access to Services for Displaced Populations and Host Communities in Acute and Protracted Emergencies

1. Priorities for addressing substance use disorder in humanitarian settings

2. Substance Use Among Populations Displaced by Conflict: Assessments, Findings, Recommendations

Psychological reactance and adolescent cannabis use: the role of parental warmth and monitoring

Embracing public health approaches to gambling? A review of global legislative and regulatory trends

Attitudes towards alcohol policy in Europe; results of the alcohol survey in 33 European countries

New problems, new approaches: Actions for the case of non-substance addictions for adolescents and young adults

2. Training of trainers package on FAS/FASD prevention

3. Piloting an evidence-based good practice intervention for reducing the risk of FASD

1. Guidelines to reduce alcohol consumption in women of child-bearing age

1. Annual incidence of substance-induced psychoses in Scandinavia from 2000 to 2016

2. Characteristics of incident substance-induced psychosis compared to incident first episode psychosis. A nationwide register-linkage study

3. Relapse rate of substance-induced psychosis and associated risk factors. A nationwide registerlinkage study

4. Substance-induced psychosis and later schizophrenia or bipolar disorder: transition rates and the role of infections

5. Antipsychotic use and associating factors among persons with substance-induced psychosis and first-episode psychosis. A nationwide register-linkage study

A qualitative exploration of patient’s experience of mobile telephone-delivered Contingency Management (mCM) to promote adherence to supervised methadone in UK pharmacies

I don’t chase drugs anymore and I’m not dead': The Impact of Safer Opioid Supply Programs in Ontario Canada on Client’s Health and Drug Use

Delivering telemedicine to vulnerable people with opioid use disorder: Outcomes of a program co-constructed and implemented with a community-based harm reduction service in Montreal, Canada

Access to their own drugs': Navigating the drawbacks and benefits of injectable hydromorphone and diacetylmorphine treatment in Vancouver, BC

Treatment-seeking problem gamblers: characteristics of individuals who offend to finance gambling

Characterizing habit formation in modern slot machine gambling

A scoping review on cryptocurrency trading among young people and its association with gambling and mental health

Cue-reactivity and inhibitory control in behavioral addcitions: an overview of functional neuroimaging studies

Changes in social work practice and support for people who use drugs during the Covid-19 pandemic – a case study of Malmö, Sweden

2. Individuals dying of overdoses related to pharmaceutical opioids differ from individuals dying of overdoses related to other substances

3. Changes in primary cause of overdose deaths following liberalisations in opioid prescription practices and differences in overdose death correlates.

4. Fatal overdoses in a cohort of chronic pain patients

Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysis

Anti-doping knowledge and educational needs of Finnish pharmacists

The implementation of ultra-portable devices for analysis of illicit drug in drug checking service of the Canton of Vaud (Switzerland, CH)

Characteristics of acute ecstasy-related toxicity in multiple Dutch medical settings, from 2009 through 2018

Metabolite profiling of synthetic cathinones: towards the identification of consumption biomarkers in forensic and clinical settings

Substance Use and Substance Use Disorders in relation to COVID-19: Qualitative Experience of Users in Jordan

Overdose deaths and the COVID-19 pandemic in British Columbia, Canada

1. Characteristics of suicides among overdose deaths in Norway in 2016-2020

Drug use and attitudes toward COVID-19 vaccination in a representative sample of undergraduate students

2. Medical use of cannabis and cannabinoids: an overview of evidence

5. Treatment of cannabis-related problems in Europe: a typology and evidence overview

3. Cannabis-related effects and harms: a scientific overview

4. Harm reduction for cannabis related problems in Europe and beyond

1. Gender-sensitive drug policy

2. Youth-centered drug policy

3. Perspectives of people who use drugs on drug policy

Getting your addiction research published: seminar

Alcohol consumption, impact of COVID-19 and alcohol-attributable disease burden: a global update

Global alcohol action plan 2020-2030

European framework for action on alcohol 2022-2025

1. Community perspective on access to harm reduction

2. Documenting Egypt’s adoption and upcoming rollout of OAT

3. Introducing the WHO Consolidated guidelines for key populations

4. Introducing the UNODC-WHO OAT Operational tool and training package

4. The Impact of the Russian Invasion of Ukraine on Needle and Syringe Distribution by Harm Reduction Organizations

1. Equitable substance use treatment for migrants, refugees and ethnic minorities: An emerging research domain

2. Substance use disorders in refugee and migrant groups in Sweden: A nationwide cohort study of 1.2 million people

5. Services for vulnerable Migrants who use Drugs in the EU (SEMID-EU)

3. Smartphone-based addiction prevention for young refugees: results of a feasibility study

1. ABC-Training: A New Proposition-Based Variety of Cognitive Bias Modification. Theoretical Background and Initial Results.

2. Phenotyping Individuals with Alcohol Use Disorder: Implications for Precision Medicine and Predicting Non-Abstinent Recovery from Alcohol Use Disorder

3. Examining a Brief Measure and Observed Cutoff Scores to Identify Reward and Relief Drinking Profiles: Psychometric Properties and Pharmacotherapy Response

Assessing the impact of COVID-19 and associated control measures on interventions to prevent drug-related harm among people who inject drugs in Scotland

The Contribution of Unstable Housing to HIV and Hepatitis C Virus Transmission Among People Who Inject Drugs Globally, Regionally, and at Country Level: A Modelling Study

The effectiveness of low dead space syringes for reducing the risk of hepatitis C virus acquisition among people who inject drugs - findings from a national survey in UK

Global incidence of hepatitis C virus (HCV) and HIV infection among people who inject drugs: A systematic review and meta-analysis

Online gambling and associated harms during the COVID-19 pandemic: A population study

Online gambling and F2P games in Canada: portrait and trends

Problem gambling among European adolescents: potential risk of gambling products and online gambling

Cryptocurrency trading as behavioral addiction: cross-sectional and longitudinal perspective from Finland

5. The U.S. Cannabis Policy Scale: Moving Beyond Dichotomous Measures to Evaluate Impacts of Liberalization Policies on Cannabis and Other Substance Use Outcomes

2. Measuring the impacts of a new cannabis regulation in Luxembourg: the need for valid data collection methods

3. The Swiss pilot trials with cannabis – evaluation after one year

4. The Dutch closed cannabis supply chain experiment: background, design of the evaluation study and challenges

1. Prevention Science and the Professionalization of Prevention Practice

3. Training the Prevention Workforce-Future Prevention Workforce

2. International Credentialling

Digital technologies to prevent drug overdoses. A UK perspective